Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Motor Activity 12Breast Neoplasms 9Neoplasms 6Leukemia, Myeloid, Acute 3Prostatic Neoplasms 2Patient Compliance 2Neoplasm Metastasis 2Fatigue 2Depression 2Colorectal Neoplasms 2Brain Neoplasms 2Weight Loss 1Weight Gain 1Smoking Cessation 1Peripheral Nervous System Diseases 1Overweight 1Ovarian Neoplasms 1Obesity 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Lung Neoplasms 1Insulin Resistance 1Infratentorial Neoplasms 1Fallopian Tube Neoplasms 1Disease 1Cognitive Dysfunction 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Bone Metabolism Biomarkers 1Body Weight Changes 1

Interventions

Cyclophosphamide 18Etoposide 12Cisplatin 11Temozolomide 10Vincristine 9Radiotherapy 9Magnetic Resonance Spectroscopy 9Filgrastim 8Irinotecan 7Carboplatin 7X-Rays 6Phantoms, Imaging 6Topotecan 5Specimen Handling 5Peripheral Blood Stem Cell Transplantation 5Nuclear Medicine Department, Hospital 5Thiotepa 4Radiation 4Lomustine 4Biopsy 4Bevacizumab 4tipifarnib 3sargramostim 3palbociclib 3Methotrexate 3HhAntag691 3Chemotherapy, Adjuvant 3ulixertinib 2tazemetostat 2sonidegib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Medulloblastoma × Exercise × Clear all
NCT01878617 2025-11-13

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
660 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Infratentorial Neoplasms, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡